The Commission for the Financial Market (CMF) reported that the new president of the institution, Catherine Tornel, decided to suspend the listing and trading of shares and bonds of Clínica Las Condes (CLC). This will occur, according to the CMF in a statement, “until April 15, 2026, or until the company submits its audited financial statements as of December 31, 2025. ” The resolution is based on the fact that “as of the date, and according to what the company communicated to the CMF on March 26, 2026, Clínica Las Condes S.
A. has not sent its financial information to the CMF as of December 31, 2025, the deadline for which expired on March 31, 2026,” the agency pointed out. “Given the above, investors, shareholders, and the market in general do not have truthful, sufficient, and timely information about the financial situation of this company and, therefore, about its securities,” it added.
The CMF disclosed in the resolution that on March 26, CLC sent a communication to the regulator, explaining that due to the change of control of the company that occurred on January 10, 2025, “the current board, in collaboration with its main executives, detected manual adjustments that could affect the financial statements. ” Therefore, CLC informed the CMF that “the current board has instructed actions to detect, investigate, correct, and report the reported facts, which has involved analyzing a large amount of information by the external auditors from Deloitte in order to provide the market with complete and truthful information. ” They then indicated that this “will necessarily cause a delay in the disclosure of the financial statements committed to March 31, 2026, so I inform you that CLC must disclose its financial statements for the year 2025, no later than April 15, 2026.
” However, in its resolution, the CMF maintains that according to current regulations, “annual financial statements must be submitted within 90 calendar days from the closing date of the respective calendar quarter. However, as of the date of this resolution, the company has not submitted its financial statements as of December 31, 2025. ” They added that this “implies that investors, shareholders, and the market in general do not have truthful, sufficient, and timely information about the financial situation of this company, so, due to the public interest and the protection of investors, it is appropriate to suspend the listing and trading of CLC’s shares and bonds.
” This is because, in the opinion of the CMF, “what has occurred constitutes a serious situation, since such information…
5 of Article 21 of the aforementioned Decree Law No. 3,538, it is the responsibility of the President of the Commission to provisionally suspend, in serious and urgent cases, the listing and trading of the shares of Clínica Las Condes S. A.
, when required by the public interest or the protection of investors, which will be carried out in the terms of the resolutive of this administrative act.